Clear Street Maintains Buy on Janux Therapeutics, Lowers Price Target to $32

Benzinga · 3d ago
Clear Street analyst Kaveri Pohlman maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and lowers the price target from $80 to $32.